SMSPHARMA — SMS Pharmaceuticals Share News
0.000.00%
- IN₹47.58bn
- IN₹50.69bn
- IN₹8.87bn
Brief: SMS Pharmaceuticals Gets Certificate of Suitability Approval For Ibuprofen
Brief: SMS Pharmaceuticals Dec-Quarter Consol Net Profit Falls
Brief: SMS Pharmaceuticals Sept-Quarter Consol Net Profit Rises
Brief: SMS Pharma Reports Higher March-Quarter Profit
Brief: SMS Pharmaceuticals Ltd Dec Quarter Consol Net Profit Rises
Brief: India's SMS Pharmaceuticals Sept-Quarter Consol Net Profit Rises
Brief: SMS Pharma Says "Strongly Condemn" News On Divis Labs Buying Co's Stake
Brief: India's SMS Pharmaceuticals June Quarter Consol Net Profit Falls
Brief: Sms Pharmaceuticals Says Promoter Intends To Buy 6.46% Stake In Co
Brief: India's SMS Pharmaceuticals March-Quarter Consol Net Profit Falls
Brief: SMS Pharma Updates On USFDA Statement On Ranitidine
Brief: SMS Pharmaceuticals Declares Interim Dividend Of 0.25 Rupees Per Equity Share
Brief: SMS Pharmaceuticals Says EDQM Completes Inspection Of Bachupally API Facility, Hyderabad
Brief: SMS Pharmaceuticals Says Co, Chemo Agreed To Register JV In Spain Instead Of Switzerland
Brief: India's SMS Pharmaceuticals June-Qtr Consol Net PAT Rises
Brief: India's Sms Pharmaceuticals March Quarter Net Profit Falls
Brief: India's SMS Pharmaceuticals Dec Qtr Net Profit Rises
Brief: SMS Pharmaceuticals Gets EIR From U.S. FDA for Manufacturing Facility in Hyderabad
Brief: India's SMS Pharmaceuticals Sept-Qtr Profit Rises